Clostridium Difficile Agar (7385)
| Brand |
Product Code |
| Acumedia |
7385 |
Intended Use
Clostridium Difficile Agar serves a critical role in microbiological diagnostics. This selective medium is specifically designed for the isolation of Clostridium difficile when used in conjunction with blood, Cycloserine, and Cefoxitin. It enables microbiologists and laboratory technicians to efficiently identify this significant pathogen.
Product Summary and Explanation
Clostridium difficile is recognized as a leading cause of antibiotic-associated diarrhea and pseudomembranous colitis. Its prevalence as a pathogen continues to rise, making it a significant concern in nosocomial infections prevalent in hospitals and nursing homes. This adaptable organism has been identified in various environments including soil, hay, sand, and animal waste from mammals, as well as in human feces.
The development of Clostridium Difficile Agar is rooted in the foundational work by George et al. in 1979, who introduced the CCFA (Cycloserine-Cefoxitin-Fructose agar) formulation, which modified McClung and Toabe's Egg Yolk Agar to utilize fructose instead of glucose. This product represents an evolved version of the original CCFA medium, refined for enhanced performance in laboratory settings.
Specifications
- Format: Modification of CCFA
- Component Variances: Incorporates blood, Cycloserine, and Cefoxitin
Utilizing Clostridium Difficile Agar in your laboratory practice ensures precise detection and understanding of Clostridium difficile infections, thereby facilitating timely and effective management of this important health issue.
